Palatin Technologies, Inc.
General ticker "PTN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $27.9M (TTM average)
Palatin Technologies, Inc. does not follow the US Stock Market performance with the rate: -12.7%.
Estimated limits based on current volatility of 8.9%: low 14.97$, high 17.89$
Factors to consider:
- Total employees count: 30 (-11.8%) as of 2024
- Top business risk factors: Insufficient funding, Dependence on successful product commercialization, Economic downturns and volatility, Cybersecurity threats, Regulatory and compliance
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-06-30 to 2027-06-30
- 2025-06-30 to 2026-06-30 estimated range: [5.34$, 23.31$]
- 2026-06-30 to 2027-06-30 estimated range: [4.19$, 16.42$]
Financial Metrics affecting the PTN estimates:
- Negative: with PPE of -1.4 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -539.70 <= 0.04
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: Shareholder equity ratio, % of -146.22 <= 19.35
- Negative: negative Industry operating income (median)
Short-term PTN quotes
Long-term PTN plot with estimates
Financial data
| YTD | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating Revenue | $4.85MM | $4.49MM | $0.00MM |
| Operating Expenses | $37.31MM | $26.99MM | $22.71MM |
| Operating Income | $-32.46MM | $-22.50MM | $-22.71MM |
| Non-Operating Income | $3.75MM | $-7.24MM | $5.40MM |
| Interest Expense | $0.02MM | $0.02MM | $0.02MM |
| R&D Expense | $22.63MM | $22.40MM | $14.90MM |
| Income(Loss) | $-28.71MM | $-29.74MM | $-17.31MM |
| Taxes | $-4.67MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $-20.53MM | $-29.74MM | $-17.31MM |
| Stockholders Equity | $0.13MM | $-0.11MM | $-4.78MM |
| Inventory | $0.53MM | $0.00MM | $0.00MM |
| Assets | $17.94MM | $10.74MM | $3.27MM |
| Operating Cash Flow | $-29.27MM | $-31.46MM | $-21.31MM |
| Capital expenditure | $0.43MM | $0.04MM | $0.00MM |
| Investing Cash Flow | $-3.43MM | $12.45MM | $3.13MM |
| Financing Cash Flow | $10.75MM | $20.55MM | $11.21MM |
| Earnings Per Share** | $-1.89 | $-2.02 | $-32.15 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.